Asia Pacific Healthcare Fund II
BioScience Managers Translation Fund I
Avita Medical (ASX:AVH) is a global regenerative medicine company that provides a novel approach to skin regeneration whose products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. AVITA’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical’s first product, the RECELL® System, is a device that enables healthcare professionals to produce a suspension of Spray-On Skin™ Cells using a small sample of the patient’s own skin. This suspension contains the cells necessary to regenerate the outer layer of natural, healthy skin and is prepared and applied at the point-of-care in as little as 30 minutes.